Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus
Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24‐week, double‐blind, randomized trial
VILDAGLIPTIN
Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12‐week, randomized, double‐blind, active‐controlled study
Liraglutide/vildagliptin
Teneligliptin/vildagliptin
Linagliptin/vildagliptin